Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

UK MHRA Finalizes Strategy For Embedding Patient And Public Voice In Its Work

Executive Summary

The UK MHRA has pushed back the timelines for delivering some of the objectives listed in its first five-year strategy on involving patients and public in regulatory decision-making.

You may also be interested in...



UK Regulator Wants More Patient/Public Involvement In Decision-Making

In launching its latest consultation, the MHRA says it wants to see much more focus on the role of the ‘patient and public voice’ in shaping the way it makes regulatory decisions.

EMA Consults On Proposed Framework For Patient Preference Studies

The EMA is inviting feedback on its plans to ratify, with some caveats, a new framework on how to use patient preferences as input in medical product decision-making. The framework was developed under the EU’s public-private Innovative Medicines Initiative.

Sweden Tackles Regulatory Barriers To Decentralized Trials

The COVID-19 pandemic has given a new impetus to Sweden’s ongoing efforts to support decentralized clinical trials. 

Topics

UsernamePublicRestriction

Register

PS145038

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel